Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Business update

16 Oct 2013 07:00

RNS Number : 5917Q
Tern PLC
16 October 2013
 



16 October 2013

 

Tern Plc

(AIM: TERN)

 

 Business update, Proposed Capital Reorganisation and new Articles

 

Tern Plc ("the Company"), the AIM-quoted investment company focussed on the fast changing IT sector, is pleased to announce a business update and capital reorganisation:

 

Business Update

 

The Company is in the final stages of making its first investment in addition to other investment opportunities which are at various stages of investigation. The Board is very pleased with the quantity and quality of the proposals received.

 

Over the past two months many of the outstanding legacy issues have been resolved. However, two require the approval of shareholders and therefore the Company is convening a General Meeting to approve a share consolidation and subdivision alongside the adoption of new articles, the reasons for which are described below.

 

The resolution of legacy issues will allow the directors to concentrate on building the Company and creating value for shareholders.

 

Share consolidation and subdivision

 

Tern plc has distributed a Circular to shareholders convening a General Meeting ("GM") for 1 November 2013.

 

At close of business on 14 October 2013, the latest practical date prior to publication of the Circular, the Company had 478 Shareholders of which 351 had a shareholding of less than 1,000 shares. These 351 Shareholders account for 73.4 per cent. of the Shareholders by number, but represent less than 0.0155% per cent. of the total number of Existing Ordinary Shares.

 

At the closing bid price of 0.235p on 14 October 2013, the latest practical date prior to the publication of the Circular, the market value of 1,000 shares would be £2.35. The Directors consider that should a shareholder with 1,000 shares or less choose to sell their shares, the proceeds will be significantly reduced or even completely eliminated by the dealing costs of selling. Therefore the Directors recognise that for small Shareholders it is uneconomic for them to dispose of their shares.

 

Capital Reorganisation

 

Under the Capital Reorganisation, the Existing Ordinary Shares will be consolidated into New Consolidated Ordinary Shares on the basis of one New Consolidated Ordinary Share for each 1,000 Existing Ordinary Shares. Each New Consolidated Ordinary Share will then be sub-divided into 50 New Ordinary Shares.

 

The rights attaching to the New Ordinary Shares will be pari passu in all respects to those of the Existing Ordinary Shares.

 

Existing share certificates will cease to be valid following the Capital Reorganisation. New share certificates in respect of the New Ordinary Shares will be issued by 11 November 2013.

 

A CREST Shareholder will have their CREST account credited with their New Ordinary Shares following their Admission, which is expected to be on 4 November 2013.

 

The notice of GM set out in the circular contains resolutions to give effect to the proposed Capital Reorganisation. The Capital Reorganisation is conditional upon the approval of the Shareholders at the GM.

 

Fractional Entitlements

 

Many Shareholders will not hold at the Record Date a number of Existing Ordinary Shares that is exactly divisible by the consolidation ratio. The result of the Consolidation, if approved, will be that such Shareholders will be left with a fractional entitlement to a resulting new Ordinary Share.

 

Holders of fewer than 1,000 Existing Ordinary Shares would not be entitled to receive New Ordinary Shares under the Consolidation. Shareholders with a holding of Existing Ordinary Shares which is greater than 1,000 but which is not exactly divisible by 1,000 would have their entitlement rounded down to the nearest whole thousand. Any fractions arising as a result of the Consolidation will be aggregated and sold for the best price reasonably obtainable, and the net proceeds of the sale distributed among such Shareholders unless the Directors consider that the cost of distribution would, in the reasonable opinion of the Board, be disproportionate to the amounts involved.

 

The Directors have decided that the costs of distributing any amounts less than £3 would be disproportionate to the amounts being distributed. Based on the current price of Existing Ordinary Shares, the maximum value of any fractional entitlement will be less than £2.35. Therefore, all proceeds of the sale of fractional entitlement arising as a consequence of the Capital Reorganisation will be sold for the benefit of the Company.

 

Adoption of Articles

 

The Directors have decided, subject to shareholders' approval, to adopt new articles which shall replace the existing articles of association. The new articles of association are updated in accordance with the Companies Act 2006 and are available for viewing on the Company's website, www.silvermere-energy.com.

 

 

The Definitions which apply in the Circular have been used in this announcement.

 

Enquiries

Tern plc

www.silvermere-energy.com

Angus Forrest, Chairman

07973 561 232

WH Ireland Limited

www.wh-ireland.co.uk

John Wakefield

0117 945 3471

Peterhouse Corporate Finance (Joint broker)

www.pcorpfin.com

Jon Levinson/Lucy Williams

020 7469 0935

Bishopsgate Communications

www.bishopsgatecommunications.com

Maxine Barnes/Nick Rome/Sam Allen

020 7562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFWFMIFDSEES
Date   Source Headline
16th Dec 20247:01 amRNS-ROnline Investor Presentation and Q&A Session
16th Dec 20247:00 amRNSPlacing to raise £400,000
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSBoard Changes
25th Oct 20248:27 amRNSFurther re. Wyld Networks Rights Issue
15th Oct 20247:00 amRNSPlacing to raise £625,000
30th Sep 20245:04 pmRNSTotal Voting Rights
30th Sep 20247:00 amRNSDevice Authority Update
23rd Sep 202411:13 amRNSReplacement: Results of Open Offer
23rd Sep 202411:10 amRNSResult of General Meeting
23rd Sep 20247:00 amRNSResults of Open Offer
5th Sep 20247:00 amRNSOpen Offer and Notice of General Meeting
5th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
2nd Sep 202410:16 amRNSStatement re Wyld Networks Rights Issue
9th Aug 20247:00 amRNSPartial sale of Device Authority holding
27th Jun 202412:00 pmRNSResult of AGM
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResults for the year ended 31 December 2023
15th May 20247:00 amRNSExercise of Warrants
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.